These HIV Phase II trials have been designed in coordination with BP & Board of experts in the HIV field to obtain the data required. Any negotiations will be a continuation from extensive talks from prior results. Covid will be key to demonstrating broad spectrum direct acting antiviral activity in humans and may put a spanner in the works when it comes to prior extensive negotiations.
Also please name a Biotech on ASX who entitled to and not claiming R&D tax offset?
Results to Seal a Deal, page-91
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $27.97M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 3.0¢ | $21.36K | 696.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 916074 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 120000 | 2 |
View Market Depth
| Last trade - 13.55pm 30/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |